[go: up one dir, main page]

GR861847B - Process for obtaining proanthocyanidine a2 pharmaceutical compositions and their therapeutic use - Google Patents

Process for obtaining proanthocyanidine a2 pharmaceutical compositions and their therapeutic use

Info

Publication number
GR861847B
GR861847B GR861847A GR860101847A GR861847B GR 861847 B GR861847 B GR 861847B GR 861847 A GR861847 A GR 861847A GR 860101847 A GR860101847 A GR 860101847A GR 861847 B GR861847 B GR 861847B
Authority
GR
Greece
Prior art keywords
proanthocyanidine
obtaining
pharmaceutical compositions
therapeutic use
injuries
Prior art date
Application number
GR861847A
Other languages
English (en)
Inventor
Dostert Phillippe
Gabetta Bruno
Magistretti Jose Maria
Original Assignee
Idb Holding Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idb Holding Spa filed Critical Idb Holding Spa
Publication of GR861847B publication Critical patent/GR861847B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR861847A 1985-07-19 1986-07-16 Process for obtaining proanthocyanidine a2 pharmaceutical compositions and their therapeutic use GR861847B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858518289A GB8518289D0 (en) 1985-07-19 1985-07-19 Obtaining proanthocyanidine a2

Publications (1)

Publication Number Publication Date
GR861847B true GR861847B (en) 1986-09-17

Family

ID=10582551

Family Applications (1)

Application Number Title Priority Date Filing Date
GR861847A GR861847B (en) 1985-07-19 1986-07-16 Process for obtaining proanthocyanidine a2 pharmaceutical compositions and their therapeutic use

Country Status (10)

Country Link
US (3) US4863956A (el)
EP (1) EP0210785B1 (el)
JP (1) JPS6277390A (el)
KR (1) KR870000927A (el)
AT (1) ATE56868T1 (el)
DE (1) DE3674500D1 (el)
ES (1) ES2000532A6 (el)
GB (1) GB8518289D0 (el)
GR (1) GR861847B (el)
PT (1) PT83007B (el)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917323D0 (en) * 1989-07-28 1989-09-13 Inverni Della Beffa Spa Methods and pharmaceutical compositions for the treatment of ophthalmic diseases
IT1231725B (it) * 1989-08-11 1991-12-21 Inverni Della Beffa Spa Procedimento per la preparazione di estratti ad alto contenuto in antocianosidi.
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
IT1270602B (it) * 1994-07-12 1997-05-07 Indena Spa Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
US5470874A (en) * 1994-10-14 1995-11-28 Lerner; Sheldon Ascorbic acid and proanthocyanidine composition for topical application to human skin
FI955691L (fi) * 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet
US5683678A (en) * 1995-03-09 1997-11-04 The Procter & Gamble Company Oral compositions
AU742198B2 (en) * 1996-04-02 2001-12-20 Mars, Incorporated Cocoa extract compounds and methods for making and using the same
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
FR2770228B1 (fr) * 1997-10-27 1999-12-10 Greentech Sa Procede d'obtention d'oligomeres de proanthocyanidines par biofermentation et leur utilisation dans des compositions cosmetiques, dietetiques, pharmaceutiques, chimiques et alimentaires
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
US6245336B1 (en) 1999-03-11 2001-06-12 Dry Creek Nutrition, Inc. Prevention and treatment of acetaminophen toxicity with grape seed proanthocyanidin extract
US6291517B1 (en) 1999-11-19 2001-09-18 Dry Creek Nutrition, Inc Method for preventing or reducing stress-induced gastric injury using grape seed proanthocyanidin extract
US6228387B1 (en) 2000-01-27 2001-05-08 Murray Borod Integrated comprehensive hemorrhoid treatment compositions and regimen
US7306815B2 (en) * 2000-08-31 2007-12-11 Phenolics, Llc Compositions enriched in phenolic compounds and methods for producing the same
DE60120209T2 (de) * 2000-08-31 2007-03-29 Phenolics Llc Effiziente methode zur herstellung von zusammensetzungen, die mit anthocyaninen angereichert sind
US6960360B2 (en) * 2000-08-31 2005-11-01 Phenolics, Llc Efficient method for producing compositions enriched in total phenols
US6706756B1 (en) 2001-11-16 2004-03-16 University Of South Florida Vasodilating compound and method of use
DE50308279D1 (de) * 2003-06-24 2007-11-08 Cognis Ip Man Gmbh Extrakte von Litchi sinensis enthaltend oligomere Proanthocyanidine
TWI279231B (en) * 2003-10-02 2007-04-21 Asahi Breweries Ltd Neutralization agent of vacuolization toxin
JP5456955B2 (ja) * 2004-01-28 2014-04-02 マース インコーポレーテッド Ａタイプのプロシアニジンを含有する組成物およびその使用方法
US20060073220A1 (en) * 2004-07-08 2006-04-06 Daugherty F J Cinnamon extract enriched for polyphenols and methods of preparing same
TWI273911B (en) * 2005-01-18 2007-02-21 Univ Nat Chiao Tung Prevention and amelioration of acetaminophen toxicity with tea melanin
US20060293258A1 (en) * 2005-06-23 2006-12-28 Peter Rohdewald Method and composition to treat skin ulcers
CA2657803C (en) 2006-05-01 2019-01-08 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
DE102009005201A1 (de) * 2009-01-20 2010-07-22 Universität Rostock Verwendung von Polyphenol-haltigen Pflanzenextrakten zur Behandlung von Adipositas und Diabetes mellitus Typ 2
IT1398624B1 (it) 2009-02-02 2013-03-08 Dermogyn S R L Uso cosmetico della proantocianidina a2
JP5459699B2 (ja) * 2009-03-27 2014-04-02 キッコーマン株式会社 クランベリー抽出物及びその製造方法
ITMI20111671A1 (it) 2011-09-16 2013-03-17 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
CN102924466A (zh) * 2012-11-28 2013-02-13 华东理工大学 一种简便的合成[3.3.1]-双环缩酮及其衍生物的新方法
CN103467477B (zh) * 2013-07-24 2015-07-29 中国科学院华南植物园 原花青素a2及其制备方法和应用
EP2829277A1 (en) 2013-07-26 2015-01-28 Natac Biotech, S.L. Use of a-type proanthocyanidins in treating a mineralocorticoid receptor related disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1584725A (el) * 1968-01-30 1970-01-02
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
FR2480601A1 (fr) * 1980-04-22 1981-10-23 Science Union & Cie Nouveau medicament a base de biflavanone
US4443472A (en) * 1982-03-15 1984-04-17 Richter Gedeon Vegyeszeti Gyar R.T. Method of treating mammals for effects of neuro- and cardiovascular toxins

Also Published As

Publication number Publication date
GB8518289D0 (en) 1985-08-29
DE3674500D1 (de) 1990-10-31
US4925871A (en) 1990-05-15
PT83007A (en) 1986-08-01
KR870000927A (ko) 1987-03-10
ES2000532A6 (es) 1988-03-01
EP0210785A1 (en) 1987-02-04
JPS6277390A (ja) 1987-04-09
EP0210785B1 (en) 1990-09-26
US4863956A (en) 1989-09-05
ATE56868T1 (de) 1990-10-15
US4925870A (en) 1990-05-15
PT83007B (pt) 1988-07-01

Similar Documents

Publication Publication Date Title
GR861847B (en) Process for obtaining proanthocyanidine a2 pharmaceutical compositions and their therapeutic use
DK85786D0 (da) Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
NO883340D0 (no) Fremgangsmaate og anordning for planting av klumpplanter.
DK203787A (da) Praeparat til nasal administrering
BE880201A (fr) Proteines purifiees, procede de preparation et compositions pharmaceutiques les contenant
AU570506B2 (en) Intra-pocket drug delivery devices for treatment of periodontal diseases
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
EP0283505A4 (en) Vaccine and method of preparation.
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
DK462588D0 (da) 5-hydroxy-3-aminokromanforbindelser, fremgangsmaade til deres fremstilling, farmaceutiske praeparater indeholdende dem og fremgangsmaader til behandling dermed
HU907959D0 (en) Medical preparations
DE3778587D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
NO167664C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.
IE45054L (en) Veterinary composition
MA19731A1 (fr) Isomere levogyre de la mequitazine , son procede de praparation et medicaments le contenant .
IT1142590B (it) Procedimento per la produzione di ormone umano della crescita
AU4058789A (en) Medicinal drug, method of treatment of human diseases therewith, and method and device for producing and preserving thereof
IE870577L (en) Topical amide preparation
ES8304152A1 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE68909750D1 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
DK637389A (da) Plantebehandlingspraeparat